Article
Dermatology Drives Autoimmune Market Growth
IQVIA Forecast Link
Aug 11, 2022

The autoimmune market is estimated at $154 billion in 2021, with IQVIA's Forecast Link expecting a rise to $193 billion over the next 10 years. This is despite the anticipated biosimilar erosion for major biologics in the USA in the coming years, which is offset by multiple new launches across the market. The USA is proportionally twice as influential in the autoimmune market, compared to sales from the rest of the prescription market. Treated patient numbers from IQVIA's Patient Link show the varying penetration of biologics into each patient population, driven by differences in disease severity and market maturity.

Related solutions

Contact Us